Dennis Henner is 10% at ACHILLION PHARMACEUTICALS INC (ACHN). They have made 9 open-market trades across 7 companies since 2007, most recently 2023-01-11.
CIK 0001249153
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $6.2M since 2007, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FTSV | 3,616,951 | $345.5M |
| ACHN | 10,553,001 | $71.3M |
| RDUS | 1,294,134 | $38.8M |
| ETRM | 1,669,753 | $3.4M |
| ARYX | 3,576,862 | — |
| KBIO | 2,319,401 | — |
| SOMX | 3,783,185 | — |
| VRUS | 4,061 | — |
| AVNR | 15,392,318 |
Shares reported on the most recent Form 4, priced at the 2018-07-02 close. 7 holdings could not be priced and are excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FTSV | BUY | 2018-07-02 | 2018-07-02 | $16.00 | $3.2M | -3.0% | +1.1% | -5.2% |
| SOMX | SELL | 2012-06-05 | 2012-06-07 | $0.29 | $11K | N/A | N/A | N/A |
| ACHN | SELL | 2012-05-31 | 2012-06-04 | $7.49 | $9.9M | -25.7% | -1.9% | -1.9% |
| ZLCS | SELL | 2011-10-25 | 2011-10-27 | $1.02 | $287K | N/A | N/A | N/A |
| ZLCS | SELL | 2011-09-26 | 2011-09-28 | $1.10 | $451K | N/A | N/A | N/A |
| AVNR | SELL | 2010-07-13 | 2010-07-15 | $3.53 | $582K | N/A | N/A | N/A |
| VRUS | SELL | 2008-04-02 | 2008-04-02 | $20.00 | $108K | N/A | N/A | N/A |
| VRUS | SELL | 2008-02-07 | 2008-02-11 | $22.55 | $549K | N/A | N/A | N/A |
| ARYX | BUY | 2007-11-13 | 2007-11-13 | $10.00 | $3.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| — |
| ZLCS | 11,872,768 | — |
| CRXX | 14,633,961 | — |
| Total | $459.0M |